August 10, 2021
Dermavant Announces FDA Acceptance for Filing of N ...
Read More
June 3, 2021
Dermavant Submits New Drug Application (NDA) to FD ...
Read More
April 16, 2021
Dermavant Announces Tapinarof Data Presentations a ...
Read More
January 15, 2020
Dermavant Enters into Exclusive License Agreement ...
Read More
June 5, 2019
Dermavant Sciences Announces First Patient Dosed i ...
Read More
March 27, 2019
Dermavant Sciences Announces Appointment of Cyril ...
Read More
February 21, 2019
Dermavant Sciences to Present Data on Tapinarof fo ...
Read More
January 2, 2019
Dermavant Sciences Announces Appointment of Dr. Ph ...
Read More
October 11, 2018
Dermavant Sciences to Present Tapinarof Phase 2B D ...
Read More
September 4, 2018
Dermavant Announces Changes to Leadership and Boar ...
Read More
August 21, 2018
Dermavant Sciences Announces Closing of Transactio ...
Read More
July 12, 2018
Roivant subsidiary Dermavant Sciences signs agreem ...
Read More
